Palisade Operating Income from 2010 to 2026
| PALI Stock | USD 1.60 0.03 1.84% |
Operating Income | First Reported 2006-06-30 | Previous Quarter -2.8 M | Current Value -2.9 M | Quarterly Volatility 4 M |
Check Palisade Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Palisade Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.6 K, Interest Expense of 13.1 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 17.64, Dividend Yield of 0.0 or PTB Ratio of 0.29. Palisade financial statements analysis is a perfect complement when working with Palisade Bio Valuation or Volatility modules.
Palisade | Operating Income | Build AI portfolio with Palisade Stock |
The Operating Income trend for Palisade Bio offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Palisade Bio is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Palisade Bio's Operating Income Growth Pattern
Below is the plot of the Operating Income of Palisade Bio over the last few years. Operating Income is the amount of profit realized from Palisade Bio operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Palisade Bio is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. Palisade Bio's Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Palisade Bio's overall financial position and show how it may be relating to other accounts over time.
| Operating Income | 10 Years Trend |
|
Operating Income |
| Timeline |
Palisade Operating Income Regression Statistics
| Arithmetic Mean | (14,489,344) | |
| Coefficient Of Variation | (57.49) | |
| Mean Deviation | 4,971,522 | |
| Median | (13,215,000) | |
| Standard Deviation | 8,330,028 | |
| Sample Variance | 69.4T | |
| Range | 40.3M | |
| R-Value | (0.25) | |
| Mean Square Error | 69.4T | |
| R-Squared | 0.06 | |
| Significance | 0.33 | |
| Slope | (412,588) | |
| Total Sum of Squares | 1110.2T |
Palisade Operating Income History
About Palisade Bio Financial Statements
Investors use fundamental indicators, such as Palisade Bio's Operating Income, to determine how well the company is positioned to perform in the future. Although Palisade Bio's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Operating Income | -13.4 M | -14 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Palisade Bio Correlation against competitors. For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is there potential for Biotechnology market expansion? Will Palisade introduce new products? Factors like these will boost the valuation of Palisade Bio. Anticipated expansion of Palisade directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Palisade Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Palisade Bio is measured differently than its book value, which is the value of Palisade that is recorded on the company's balance sheet. Investors also form their own opinion of Palisade Bio's value that differs from its market value or its book value, called intrinsic value, which is Palisade Bio's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Palisade Bio's market value can be influenced by many factors that don't directly affect Palisade Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Palisade Bio's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Palisade Bio should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Palisade Bio's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.